Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

The decrease in CD4 cells during HIV infection seems to be driven by ... low CD4-cell counts among patients who control viral replication without ART (so-called "elite controllers").

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

This same property also makes it useful as a therapy for people who are already infected with HIV − it reduces viral ...

HIV, or Human Immunodeficiency Virus, is a type of virus that weakens the immune system, making one susceptible to a variety of infections. Although there is no cure for HIV, with the right treatment, ...

Long-acting injectable HIV treatment leads to rectal shedding in a small proportion of patients with HIV, independent of the ...

Cleveland Clinic virology researchers have found that a specific protein modification to the immune protein MDA5 is key to how human bodies detect and respond to viruses and viral replication.

the drug reduced the viral reservoir in blood in patients with HIV. ABX464 is the company's first antiviral drug, and inhibits HIV replication through a novel mechanism, the modulation of RNA ...

Researchers at UW are pioneering long-acting injectable HIV therapies that have the potential to simplify and expand ...